Swedish-U.S. drugs group Pharmacia & Upjohn said on Thursday it was considering a stock market listing for its wholly-owned subsidiary Pharmacia Biosensor AB.   "Pharmacia & Upjohn is considering the sale of some of its shares in the wholly-owned subsidiary Pharmacia Biosensor AB. A definitive decision...will be made later on by the board on the basis of prevailing market conditions," the company said in a statement. The Biosensor unit develops, manufactures and markets analytical instruments based on its own patented biosensor technology. P&U said it intended to change the name of the unit to Biacore AB before the sale of the shares. -- Stockholm newsroom, +46-8-700 1006